share_log

SVB Leerink Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $7

Benzinga Real-time News ·  Feb 8, 2023 08:33

SVB Leerink analyst Thomas Smith maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform and lowers the price target from $9 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment